✦ LIBER ✦

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia

✍ Scribed by Shi-Fu Xiao; Hai-Bo Xue; Xia Li; Chao Chen; Guan-Jun Li; Cheng-Mei Yuan; Ming-Yuan Zhang

Book ID: 107639316
Publisher: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Year: 2011
Tongue: English
Weight: 725 KB
Volume: 27
Category: Article
ISSN: 1673-7067
DOI: 10.1007/s12264-011-1417-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sildenafil adjunctive therapy to risperi

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

✍ Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of